Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.92 CAD | +0.85% | +2.60% | +14.07% |
22/03 | Knight Therapeutics Price Target Raised to $7 at RBC | MT |
21/03 | Knight Therapeutics Reports Fourth Quarter Results | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.07% | 437M | |
+6.63% | 72.03B | |
-10.86% | 5.14B | |
+46.43% | 4.6B | |
+5.38% | 3.96B | |
-16.20% | 2.5B | |
+22.03% | 2.43B | |
-26.20% | 2.32B | |
+19.92% | 2.18B | |
+8.15% | 1.72B |
- Stock Market
- Equities
- GUD Stock
- News Knight Therapeutics Inc.
- Amneal Grants Knight Therapeutics Rights to Parkinson's Disease Drug in Canada, Latin America